VRTX·92532F100·US·equity·Healthcare - Biotechnology-13D/G
VRTX (VERTEX PHARMACEUTICALS INC) is held by 340 institutional investors as of Q1 2026. Largest holders: Capital World Investors ($11.3B), BlackRock, Inc. ($10.7B), Capital Research Global Investors ($9.4B). Net institutional sentiment: Mixed.
See how VRTX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer